Daily Bulletin

Men's Weekly

.

Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2 Social Anxiety Disorder PREVAIL Study

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
  • U.S. FDA clearance of IND for BNC210 evaluation as an acute treatment for patients with Social Anxiety Disorder in a Phase 2 clinical trial, the PREVAIL Study
  • The PREVAIL Study remains on target to initiate by end of 2021 and is expected to read out topline data by end of 2022

ADELAIDE, Australia, Nov. 1, 2021 /PRNewswire/ -- Bionomics Limited...

Read more: Bionomics Receives FDA Clearance of IND for Evaluation of BNC210 in a Phase 2 Social Anxiety...

Business News

Cleaning Australia: The Rise of Professional Cleaning Services

The cleaning industry in Australia is booming as more people are opting for professional cleaning services to keep their homes, offices, and businesses spotless. With the increasing demand for cleanli...

Daily Bulletin - avatar Daily Bulletin

How Melbourne & Sydney Facilities Are Choosing the Right Cleaning Supplies for Maximum Efficiency

Facility management is a demanding job. You oversee building operations. You ensure safety. You manage costs. A crucial part of this role is selecting the right cleaning supplies. The products you cho...

Daily Bulletin - avatar Daily Bulletin

Why Every Business Needs Wholesale Gift Boxes and Custom Packaging

candles, handmade jewellery and artisanal chocolates are just some item types where aesthetics are important to shape customer assumptions in terms of brand prestige or product quality. Pack aging ...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business